nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—TOP2A—Epirubicin—liver cancer	0.369	0.527	CbGbCtD
Amsacrine—TOP2A—Doxorubicin—liver cancer	0.196	0.28	CbGbCtD
Amsacrine—ABCB1—Sorafenib—liver cancer	0.0433	0.0617	CbGbCtD
Amsacrine—CYP2D6—Sorafenib—liver cancer	0.0408	0.0582	CbGbCtD
Amsacrine—ABCB1—Doxorubicin—liver cancer	0.0262	0.0375	CbGbCtD
Amsacrine—CYP2D6—Doxorubicin—liver cancer	0.0247	0.0353	CbGbCtD
Amsacrine—Ureteric obstruction—Epirubicin—liver cancer	0.00448	0.0261	CcSEcCtD
Amsacrine—Ejection fraction decreased—Epirubicin—liver cancer	0.00448	0.0261	CcSEcCtD
Amsacrine—Urine output—Epirubicin—liver cancer	0.00424	0.0247	CcSEcCtD
Amsacrine—Ureteric obstruction—Doxorubicin—liver cancer	0.00415	0.0242	CcSEcCtD
Amsacrine—Ejection fraction decreased—Doxorubicin—liver cancer	0.00415	0.0242	CcSEcCtD
Amsacrine—Urine output—Doxorubicin—liver cancer	0.00392	0.0229	CcSEcCtD
Amsacrine—Mucosal inflammation—Sorafenib—liver cancer	0.00359	0.0209	CcSEcCtD
Amsacrine—NCOA3—Idarubicin—Epirubicin—liver cancer	0.00277	0.368	CbGdCrCtD
Amsacrine—NCOA3—Idarubicin—Doxorubicin—liver cancer	0.00257	0.34	CbGdCrCtD
Amsacrine—Proteinuria—Sorafenib—liver cancer	0.00227	0.0132	CcSEcCtD
Amsacrine—Protein urine present—Sorafenib—liver cancer	0.00223	0.013	CcSEcCtD
Amsacrine—Injection site inflammation—Epirubicin—liver cancer	0.0022	0.0128	CcSEcCtD
Amsacrine—Blood bilirubin increased—Sorafenib—liver cancer	0.0021	0.0123	CcSEcCtD
Amsacrine—Injection site inflammation—Doxorubicin—liver cancer	0.00204	0.0119	CcSEcCtD
Amsacrine—Sinus tachycardia—Epirubicin—liver cancer	0.00183	0.0106	CcSEcCtD
Amsacrine—Sinus tachycardia—Doxorubicin—liver cancer	0.00169	0.00984	CcSEcCtD
Amsacrine—Hepatic failure—Sorafenib—liver cancer	0.00161	0.00937	CcSEcCtD
Amsacrine—Cardiac failure congestive—Sorafenib—liver cancer	0.00159	0.00928	CcSEcCtD
Amsacrine—Myelosuppression—Epirubicin—liver cancer	0.00157	0.00914	CcSEcCtD
Amsacrine—Myelosuppression—Doxorubicin—liver cancer	0.00145	0.00846	CcSEcCtD
Amsacrine—Cardiomyopathy—Epirubicin—liver cancer	0.00144	0.00837	CcSEcCtD
Amsacrine—Mood swings—Sorafenib—liver cancer	0.00137	0.00797	CcSEcCtD
Amsacrine—Cardiomyopathy—Doxorubicin—liver cancer	0.00133	0.00775	CcSEcCtD
Amsacrine—Mucosal inflammation—Epirubicin—liver cancer	0.00133	0.00774	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.0013	0.00758	CcSEcCtD
Amsacrine—Gingival bleeding—Epirubicin—liver cancer	0.0013	0.00755	CcSEcCtD
Amsacrine—Dysphagia—Sorafenib—liver cancer	0.00125	0.00728	CcSEcCtD
Amsacrine—Mucosal inflammation—Doxorubicin—liver cancer	0.00123	0.00716	CcSEcCtD
Amsacrine—Febrile neutropenia—Epirubicin—liver cancer	0.00122	0.00712	CcSEcCtD
Amsacrine—Gingival bleeding—Doxorubicin—liver cancer	0.0012	0.00699	CcSEcCtD
Amsacrine—Hypomagnesaemia—Epirubicin—liver cancer	0.00116	0.00675	CcSEcCtD
Amsacrine—Febrile neutropenia—Doxorubicin—liver cancer	0.00113	0.00659	CcSEcCtD
Amsacrine—Weight decreased—Sorafenib—liver cancer	0.00113	0.00658	CcSEcCtD
Amsacrine—Infestation NOS—Sorafenib—liver cancer	0.00111	0.00649	CcSEcCtD
Amsacrine—Infestation—Sorafenib—liver cancer	0.00111	0.00649	CcSEcCtD
Amsacrine—Renal failure—Sorafenib—liver cancer	0.00109	0.00638	CcSEcCtD
Amsacrine—Bone marrow depression—Epirubicin—liver cancer	0.00109	0.00635	CcSEcCtD
Amsacrine—Stomatitis—Sorafenib—liver cancer	0.00109	0.00632	CcSEcCtD
Amsacrine—Jaundice—Sorafenib—liver cancer	0.00109	0.00632	CcSEcCtD
Amsacrine—Hypomagnesaemia—Doxorubicin—liver cancer	0.00107	0.00624	CcSEcCtD
Amsacrine—Haematemesis—Epirubicin—liver cancer	0.00106	0.00617	CcSEcCtD
Amsacrine—Hepatobiliary disease—Sorafenib—liver cancer	0.00105	0.00614	CcSEcCtD
Amsacrine—Bone marrow depression—Doxorubicin—liver cancer	0.00101	0.00587	CcSEcCtD
Amsacrine—Haemoglobin—Sorafenib—liver cancer	0.001	0.00585	CcSEcCtD
Amsacrine—Haemorrhage—Sorafenib—liver cancer	0.000999	0.00582	CcSEcCtD
Amsacrine—Ventricular arrhythmia—Epirubicin—liver cancer	0.000994	0.00579	CcSEcCtD
Amsacrine—Urinary tract disorder—Sorafenib—liver cancer	0.000987	0.00575	CcSEcCtD
Amsacrine—Connective tissue disorder—Sorafenib—liver cancer	0.000982	0.00572	CcSEcCtD
Amsacrine—Urethral disorder—Sorafenib—liver cancer	0.00098	0.00571	CcSEcCtD
Amsacrine—Haematemesis—Doxorubicin—liver cancer	0.00098	0.00571	CcSEcCtD
Amsacrine—Necrosis—Epirubicin—liver cancer	0.000937	0.00546	CcSEcCtD
Amsacrine—Gingivitis—Epirubicin—liver cancer	0.000937	0.00546	CcSEcCtD
Amsacrine—Cardiac disorder—Sorafenib—liver cancer	0.000928	0.0054	CcSEcCtD
Amsacrine—Ventricular arrhythmia—Doxorubicin—liver cancer	0.000919	0.00536	CcSEcCtD
Amsacrine—Angiopathy—Sorafenib—liver cancer	0.000907	0.00528	CcSEcCtD
Amsacrine—Mediastinal disorder—Sorafenib—liver cancer	0.000901	0.00525	CcSEcCtD
Amsacrine—Arrhythmia—Sorafenib—liver cancer	0.000893	0.0052	CcSEcCtD
Amsacrine—Alopecia—Sorafenib—liver cancer	0.000883	0.00515	CcSEcCtD
Amsacrine—Mental disorder—Sorafenib—liver cancer	0.000876	0.0051	CcSEcCtD
Amsacrine—Malnutrition—Sorafenib—liver cancer	0.00087	0.00507	CcSEcCtD
Amsacrine—Gingivitis—Doxorubicin—liver cancer	0.000867	0.00505	CcSEcCtD
Amsacrine—Necrosis—Doxorubicin—liver cancer	0.000867	0.00505	CcSEcCtD
Amsacrine—Extravasation—Epirubicin—liver cancer	0.000843	0.00491	CcSEcCtD
Amsacrine—Anaemia—Sorafenib—liver cancer	0.000804	0.00469	CcSEcCtD
Amsacrine—Hyperuricaemia—Epirubicin—liver cancer	0.000793	0.00462	CcSEcCtD
Amsacrine—Extravasation—Doxorubicin—liver cancer	0.00078	0.00454	CcSEcCtD
Amsacrine—Leukopenia—Sorafenib—liver cancer	0.000779	0.00454	CcSEcCtD
Amsacrine—Blood bilirubin increased—Epirubicin—liver cancer	0.000778	0.00453	CcSEcCtD
Amsacrine—Creatinine increased—Epirubicin—liver cancer	0.000773	0.0045	CcSEcCtD
Amsacrine—Inflammation—Epirubicin—liver cancer	0.000758	0.00442	CcSEcCtD
Amsacrine—Blood uric acid increased—Epirubicin—liver cancer	0.000749	0.00436	CcSEcCtD
Amsacrine—Musculoskeletal pain—Epirubicin—liver cancer	0.000744	0.00434	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000736	0.00429	CcSEcCtD
Amsacrine—Phosphatase alkaline increased—Epirubicin—liver cancer	0.000736	0.00429	CcSEcCtD
Amsacrine—Hyperuricaemia—Doxorubicin—liver cancer	0.000734	0.00427	CcSEcCtD
Amsacrine—Injection site reaction—Epirubicin—liver cancer	0.000731	0.00426	CcSEcCtD
Amsacrine—Blood bilirubin increased—Doxorubicin—liver cancer	0.00072	0.00419	CcSEcCtD
Amsacrine—Creatinine increased—Doxorubicin—liver cancer	0.000715	0.00417	CcSEcCtD
Amsacrine—Infection—Sorafenib—liver cancer	0.000705	0.00411	CcSEcCtD
Amsacrine—Inflammation—Doxorubicin—liver cancer	0.000702	0.00409	CcSEcCtD
Amsacrine—Thrombocytopenia—Sorafenib—liver cancer	0.000695	0.00405	CcSEcCtD
Amsacrine—Blood urea increased—Epirubicin—liver cancer	0.000694	0.00405	CcSEcCtD
Amsacrine—Blood uric acid increased—Doxorubicin—liver cancer	0.000693	0.00404	CcSEcCtD
Amsacrine—Aplastic anaemia—Epirubicin—liver cancer	0.000691	0.00402	CcSEcCtD
Amsacrine—Skin disorder—Sorafenib—liver cancer	0.00069	0.00402	CcSEcCtD
Amsacrine—Musculoskeletal pain—Doxorubicin—liver cancer	0.000689	0.00401	CcSEcCtD
Amsacrine—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.000681	0.00397	CcSEcCtD
Amsacrine—Anorexia—Sorafenib—liver cancer	0.000677	0.00394	CcSEcCtD
Amsacrine—Injection site reaction—Doxorubicin—liver cancer	0.000677	0.00394	CcSEcCtD
Amsacrine—Blood urea increased—Doxorubicin—liver cancer	0.000642	0.00374	CcSEcCtD
Amsacrine—Aplastic anaemia—Doxorubicin—liver cancer	0.000639	0.00372	CcSEcCtD
Amsacrine—Sepsis—Epirubicin—liver cancer	0.000638	0.00372	CcSEcCtD
Amsacrine—Dyspnoea—Sorafenib—liver cancer	0.000633	0.00369	CcSEcCtD
Amsacrine—Phlebitis—Epirubicin—liver cancer	0.00062	0.00361	CcSEcCtD
Amsacrine—Decreased appetite—Sorafenib—liver cancer	0.000617	0.0036	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000614	0.00358	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000613	0.00357	CcSEcCtD
Amsacrine—Fatigue—Sorafenib—liver cancer	0.000612	0.00357	CcSEcCtD
Amsacrine—Pain—Sorafenib—liver cancer	0.000607	0.00354	CcSEcCtD
Amsacrine—Vascular purpura—Epirubicin—liver cancer	0.000597	0.00348	CcSEcCtD
Amsacrine—Hepatic failure—Epirubicin—liver cancer	0.000594	0.00346	CcSEcCtD
Amsacrine—Sepsis—Doxorubicin—liver cancer	0.000591	0.00344	CcSEcCtD
Amsacrine—Cardiac failure congestive—Epirubicin—liver cancer	0.000589	0.00343	CcSEcCtD
Amsacrine—Gastrointestinal pain—Sorafenib—liver cancer	0.000581	0.00338	CcSEcCtD
Amsacrine—Phlebitis—Doxorubicin—liver cancer	0.000573	0.00334	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000568	0.00331	CcSEcCtD
Amsacrine—Urticaria—Sorafenib—liver cancer	0.000564	0.00329	CcSEcCtD
Amsacrine—Body temperature increased—Sorafenib—liver cancer	0.000561	0.00327	CcSEcCtD
Amsacrine—Abdominal pain—Sorafenib—liver cancer	0.000561	0.00327	CcSEcCtD
Amsacrine—Purpura—Epirubicin—liver cancer	0.000554	0.00323	CcSEcCtD
Amsacrine—Vascular purpura—Doxorubicin—liver cancer	0.000552	0.00322	CcSEcCtD
Amsacrine—Hepatic failure—Doxorubicin—liver cancer	0.00055	0.0032	CcSEcCtD
Amsacrine—Lethargy—Epirubicin—liver cancer	0.000545	0.00317	CcSEcCtD
Amsacrine—Cardiac failure congestive—Doxorubicin—liver cancer	0.000545	0.00317	CcSEcCtD
Amsacrine—Affect lability—Epirubicin—liver cancer	0.000526	0.00306	CcSEcCtD
Amsacrine—Hypersensitivity—Sorafenib—liver cancer	0.000523	0.00305	CcSEcCtD
Amsacrine—Purpura—Doxorubicin—liver cancer	0.000513	0.00299	CcSEcCtD
Amsacrine—Asthenia—Sorafenib—liver cancer	0.000509	0.00297	CcSEcCtD
Amsacrine—Mood swings—Epirubicin—liver cancer	0.000506	0.00295	CcSEcCtD
Amsacrine—Lethargy—Doxorubicin—liver cancer	0.000504	0.00294	CcSEcCtD
Amsacrine—Blood creatinine increased—Epirubicin—liver cancer	0.0005	0.00291	CcSEcCtD
Amsacrine—Affect lability—Doxorubicin—liver cancer	0.000486	0.00283	CcSEcCtD
Amsacrine—Diarrhoea—Sorafenib—liver cancer	0.000486	0.00283	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000481	0.0028	CcSEcCtD
Amsacrine—Dizziness—Sorafenib—liver cancer	0.00047	0.00274	CcSEcCtD
Amsacrine—Mood swings—Doxorubicin—liver cancer	0.000468	0.00273	CcSEcCtD
Amsacrine—Blood creatinine increased—Doxorubicin—liver cancer	0.000463	0.0027	CcSEcCtD
Amsacrine—Dysphagia—Epirubicin—liver cancer	0.000461	0.00269	CcSEcCtD
Amsacrine—Vomiting—Sorafenib—liver cancer	0.000451	0.00263	CcSEcCtD
Amsacrine—Rash—Sorafenib—liver cancer	0.000448	0.00261	CcSEcCtD
Amsacrine—Dermatitis—Sorafenib—liver cancer	0.000447	0.00261	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000445	0.00259	CcSEcCtD
Amsacrine—Headache—Sorafenib—liver cancer	0.000445	0.00259	CcSEcCtD
Amsacrine—Pancytopenia—Epirubicin—liver cancer	0.000438	0.00255	CcSEcCtD
Amsacrine—Dysphagia—Doxorubicin—liver cancer	0.000427	0.00249	CcSEcCtD
Amsacrine—Nausea—Sorafenib—liver cancer	0.000422	0.00246	CcSEcCtD
Amsacrine—Weight increased—Epirubicin—liver cancer	0.00042	0.00245	CcSEcCtD
Amsacrine—Weight decreased—Epirubicin—liver cancer	0.000417	0.00243	CcSEcCtD
Amsacrine—Infestation NOS—Epirubicin—liver cancer	0.000411	0.0024	CcSEcCtD
Amsacrine—Infestation—Epirubicin—liver cancer	0.000411	0.0024	CcSEcCtD
Amsacrine—Pancytopenia—Doxorubicin—liver cancer	0.000405	0.00236	CcSEcCtD
Amsacrine—Renal failure—Epirubicin—liver cancer	0.000404	0.00236	CcSEcCtD
Amsacrine—Stomatitis—Epirubicin—liver cancer	0.000401	0.00234	CcSEcCtD
Amsacrine—Jaundice—Epirubicin—liver cancer	0.000401	0.00234	CcSEcCtD
Amsacrine—Haematuria—Epirubicin—liver cancer	0.000392	0.00229	CcSEcCtD
Amsacrine—Hepatobiliary disease—Epirubicin—liver cancer	0.000389	0.00227	CcSEcCtD
Amsacrine—Weight increased—Doxorubicin—liver cancer	0.000389	0.00226	CcSEcCtD
Amsacrine—Weight decreased—Doxorubicin—liver cancer	0.000386	0.00225	CcSEcCtD
Amsacrine—Agranulocytosis—Epirubicin—liver cancer	0.000384	0.00224	CcSEcCtD
Amsacrine—TOP2A—Daunorubicin—Epirubicin—liver cancer	0.000381	0.0505	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Epirubicin—liver cancer	0.000381	0.0505	CbGdCrCtD
Amsacrine—TOP2A—Doxorubicin—Epirubicin—liver cancer	0.000381	0.0505	CbGdCrCtD
Amsacrine—Infestation NOS—Doxorubicin—liver cancer	0.000381	0.00222	CcSEcCtD
Amsacrine—Infestation—Doxorubicin—liver cancer	0.000381	0.00222	CcSEcCtD
Amsacrine—Bradycardia—Epirubicin—liver cancer	0.000376	0.00219	CcSEcCtD
Amsacrine—Renal failure—Doxorubicin—liver cancer	0.000374	0.00218	CcSEcCtD
Amsacrine—Haemoglobin—Epirubicin—liver cancer	0.000371	0.00216	CcSEcCtD
Amsacrine—Stomatitis—Doxorubicin—liver cancer	0.000371	0.00216	CcSEcCtD
Amsacrine—Jaundice—Doxorubicin—liver cancer	0.000371	0.00216	CcSEcCtD
Amsacrine—Haemorrhage—Epirubicin—liver cancer	0.000369	0.00215	CcSEcCtD
Amsacrine—Hepatitis—Epirubicin—liver cancer	0.000369	0.00215	CcSEcCtD
Amsacrine—Hypoaesthesia—Epirubicin—liver cancer	0.000367	0.00214	CcSEcCtD
Amsacrine—Urinary tract disorder—Epirubicin—liver cancer	0.000365	0.00213	CcSEcCtD
Amsacrine—Haematuria—Doxorubicin—liver cancer	0.000363	0.00212	CcSEcCtD
Amsacrine—Connective tissue disorder—Epirubicin—liver cancer	0.000363	0.00211	CcSEcCtD
Amsacrine—Urethral disorder—Epirubicin—liver cancer	0.000362	0.00211	CcSEcCtD
Amsacrine—Hepatobiliary disease—Doxorubicin—liver cancer	0.00036	0.0021	CcSEcCtD
Amsacrine—Agranulocytosis—Doxorubicin—liver cancer	0.000355	0.00207	CcSEcCtD
Amsacrine—TOP2A—Epirubicin—Doxorubicin—liver cancer	0.000353	0.0468	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Doxorubicin—liver cancer	0.000353	0.0468	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Doxorubicin—liver cancer	0.000353	0.0468	CbGdCrCtD
Amsacrine—Bradycardia—Doxorubicin—liver cancer	0.000348	0.00203	CcSEcCtD
Amsacrine—Haemoglobin—Doxorubicin—liver cancer	0.000343	0.002	CcSEcCtD
Amsacrine—Cardiac disorder—Epirubicin—liver cancer	0.000343	0.002	CcSEcCtD
Amsacrine—Haemorrhage—Doxorubicin—liver cancer	0.000342	0.00199	CcSEcCtD
Amsacrine—Hepatitis—Doxorubicin—liver cancer	0.000342	0.00199	CcSEcCtD
Amsacrine—Hypoaesthesia—Doxorubicin—liver cancer	0.00034	0.00198	CcSEcCtD
Amsacrine—Urinary tract disorder—Doxorubicin—liver cancer	0.000338	0.00197	CcSEcCtD
Amsacrine—Connective tissue disorder—Doxorubicin—liver cancer	0.000336	0.00196	CcSEcCtD
Amsacrine—Angiopathy—Epirubicin—liver cancer	0.000335	0.00195	CcSEcCtD
Amsacrine—Urethral disorder—Doxorubicin—liver cancer	0.000335	0.00195	CcSEcCtD
Amsacrine—Mediastinal disorder—Epirubicin—liver cancer	0.000333	0.00194	CcSEcCtD
Amsacrine—Arrhythmia—Epirubicin—liver cancer	0.00033	0.00192	CcSEcCtD
Amsacrine—Alopecia—Epirubicin—liver cancer	0.000326	0.0019	CcSEcCtD
Amsacrine—Mental disorder—Epirubicin—liver cancer	0.000324	0.00189	CcSEcCtD
Amsacrine—Malnutrition—Epirubicin—liver cancer	0.000322	0.00187	CcSEcCtD
Amsacrine—Cardiac disorder—Doxorubicin—liver cancer	0.000317	0.00185	CcSEcCtD
Amsacrine—Angiopathy—Doxorubicin—liver cancer	0.00031	0.00181	CcSEcCtD
Amsacrine—Mediastinal disorder—Doxorubicin—liver cancer	0.000308	0.00179	CcSEcCtD
Amsacrine—Arrhythmia—Doxorubicin—liver cancer	0.000305	0.00178	CcSEcCtD
Amsacrine—Vision blurred—Epirubicin—liver cancer	0.000303	0.00177	CcSEcCtD
Amsacrine—Alopecia—Doxorubicin—liver cancer	0.000302	0.00176	CcSEcCtD
Amsacrine—Mental disorder—Doxorubicin—liver cancer	0.000299	0.00174	CcSEcCtD
Amsacrine—Malnutrition—Doxorubicin—liver cancer	0.000298	0.00173	CcSEcCtD
Amsacrine—Anaemia—Epirubicin—liver cancer	0.000297	0.00173	CcSEcCtD
Amsacrine—Leukopenia—Epirubicin—liver cancer	0.000288	0.00168	CcSEcCtD
Amsacrine—Vision blurred—Doxorubicin—liver cancer	0.00028	0.00163	CcSEcCtD
Amsacrine—Convulsion—Epirubicin—liver cancer	0.000279	0.00162	CcSEcCtD
Amsacrine—Anaemia—Doxorubicin—liver cancer	0.000275	0.0016	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000272	0.00158	CcSEcCtD
Amsacrine—Leukopenia—Doxorubicin—liver cancer	0.000266	0.00155	CcSEcCtD
Amsacrine—Confusional state—Epirubicin—liver cancer	0.000265	0.00154	CcSEcCtD
Amsacrine—Infection—Epirubicin—liver cancer	0.000261	0.00152	CcSEcCtD
Amsacrine—Convulsion—Doxorubicin—liver cancer	0.000258	0.0015	CcSEcCtD
Amsacrine—Thrombocytopenia—Epirubicin—liver cancer	0.000257	0.0015	CcSEcCtD
Amsacrine—Tachycardia—Epirubicin—liver cancer	0.000256	0.00149	CcSEcCtD
Amsacrine—Skin disorder—Epirubicin—liver cancer	0.000255	0.00149	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000252	0.00147	CcSEcCtD
Amsacrine—Anorexia—Epirubicin—liver cancer	0.00025	0.00146	CcSEcCtD
Amsacrine—Hypotension—Epirubicin—liver cancer	0.000245	0.00143	CcSEcCtD
Amsacrine—Confusional state—Doxorubicin—liver cancer	0.000245	0.00143	CcSEcCtD
Amsacrine—Infection—Doxorubicin—liver cancer	0.000241	0.00141	CcSEcCtD
Amsacrine—Thrombocytopenia—Doxorubicin—liver cancer	0.000238	0.00139	CcSEcCtD
Amsacrine—Tachycardia—Doxorubicin—liver cancer	0.000237	0.00138	CcSEcCtD
Amsacrine—Skin disorder—Doxorubicin—liver cancer	0.000236	0.00137	CcSEcCtD
Amsacrine—Paraesthesia—Epirubicin—liver cancer	0.000236	0.00137	CcSEcCtD
Amsacrine—Dyspnoea—Epirubicin—liver cancer	0.000234	0.00136	CcSEcCtD
Amsacrine—Anorexia—Doxorubicin—liver cancer	0.000231	0.00135	CcSEcCtD
Amsacrine—Decreased appetite—Epirubicin—liver cancer	0.000228	0.00133	CcSEcCtD
Amsacrine—Hypotension—Doxorubicin—liver cancer	0.000227	0.00132	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000227	0.00132	CcSEcCtD
Amsacrine—Fatigue—Epirubicin—liver cancer	0.000226	0.00132	CcSEcCtD
Amsacrine—Pain—Epirubicin—liver cancer	0.000224	0.00131	CcSEcCtD
Amsacrine—Paraesthesia—Doxorubicin—liver cancer	0.000218	0.00127	CcSEcCtD
Amsacrine—Dyspnoea—Doxorubicin—liver cancer	0.000216	0.00126	CcSEcCtD
Amsacrine—Feeling abnormal—Epirubicin—liver cancer	0.000216	0.00126	CcSEcCtD
Amsacrine—Gastrointestinal pain—Epirubicin—liver cancer	0.000215	0.00125	CcSEcCtD
Amsacrine—Decreased appetite—Doxorubicin—liver cancer	0.000211	0.00123	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00021	0.00122	CcSEcCtD
Amsacrine—Fatigue—Doxorubicin—liver cancer	0.000209	0.00122	CcSEcCtD
Amsacrine—Urticaria—Epirubicin—liver cancer	0.000208	0.00121	CcSEcCtD
Amsacrine—Pain—Doxorubicin—liver cancer	0.000208	0.00121	CcSEcCtD
Amsacrine—Body temperature increased—Epirubicin—liver cancer	0.000207	0.00121	CcSEcCtD
Amsacrine—Abdominal pain—Epirubicin—liver cancer	0.000207	0.00121	CcSEcCtD
Amsacrine—Feeling abnormal—Doxorubicin—liver cancer	0.0002	0.00117	CcSEcCtD
Amsacrine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000199	0.00116	CcSEcCtD
Amsacrine—Hypersensitivity—Epirubicin—liver cancer	0.000193	0.00113	CcSEcCtD
Amsacrine—Urticaria—Doxorubicin—liver cancer	0.000193	0.00112	CcSEcCtD
Amsacrine—Abdominal pain—Doxorubicin—liver cancer	0.000192	0.00112	CcSEcCtD
Amsacrine—Body temperature increased—Doxorubicin—liver cancer	0.000192	0.00112	CcSEcCtD
Amsacrine—Asthenia—Epirubicin—liver cancer	0.000188	0.0011	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—MET—liver cancer	0.000184	0.00153	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000184	0.00153	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—HRAS—liver cancer	0.000183	0.00152	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PPARA—liver cancer	0.000182	0.00152	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—liver cancer	0.000181	0.00151	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000181	0.0015	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALDOB—liver cancer	0.00018	0.0015	CbGpPWpGaD
Amsacrine—Diarrhoea—Epirubicin—liver cancer	0.00018	0.00105	CcSEcCtD
Amsacrine—CYP2D6—Biological oxidations—NR1H4—liver cancer	0.000179	0.00149	CbGpPWpGaD
Amsacrine—Hypersensitivity—Doxorubicin—liver cancer	0.000179	0.00104	CcSEcCtD
Amsacrine—CYP2D6—Biological oxidations—GSTA3—liver cancer	0.000176	0.00146	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000175	0.00146	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDKN2A—liver cancer	0.000174	0.00145	CbGpPWpGaD
Amsacrine—Asthenia—Doxorubicin—liver cancer	0.000174	0.00102	CcSEcCtD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTA3—liver cancer	0.000174	0.00144	CbGpPWpGaD
Amsacrine—Dizziness—Epirubicin—liver cancer	0.000174	0.00101	CcSEcCtD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000172	0.00143	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CRABP1—liver cancer	0.000172	0.00143	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.000171	0.00142	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—MYC—liver cancer	0.000168	0.0014	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—PPARG—liver cancer	0.000167	0.00139	CbGpPWpGaD
Amsacrine—Vomiting—Epirubicin—liver cancer	0.000167	0.000972	CcSEcCtD
Amsacrine—Diarrhoea—Doxorubicin—liver cancer	0.000166	0.000968	CcSEcCtD
Amsacrine—Rash—Epirubicin—liver cancer	0.000165	0.000964	CcSEcCtD
Amsacrine—Dermatitis—Epirubicin—liver cancer	0.000165	0.000963	CcSEcCtD
Amsacrine—Headache—Epirubicin—liver cancer	0.000164	0.000958	CcSEcCtD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000163	0.00135	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000163	0.00135	CbGpPWpGaD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—AKT1—liver cancer	0.000162	0.00134	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTA4—liver cancer	0.000161	0.00134	CbGpPWpGaD
Amsacrine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000161	0.00134	CbGpPWpGaD
Amsacrine—Dizziness—Doxorubicin—liver cancer	0.000161	0.000936	CcSEcCtD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTA4—liver cancer	0.000159	0.00132	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTA2—liver cancer	0.000157	0.0013	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000157	0.0013	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000157	0.0013	CbGpPWpGaD
Amsacrine—Nausea—Epirubicin—liver cancer	0.000156	0.000908	CcSEcCtD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000155	0.00129	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDKN1B—liver cancer	0.000154	0.00128	CbGpPWpGaD
Amsacrine—Vomiting—Doxorubicin—liver cancer	0.000154	0.0009	CcSEcCtD
Amsacrine—NCOA3—Developmental Biology—MMP2—liver cancer	0.000154	0.00128	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.000153	0.00127	CbGpPWpGaD
Amsacrine—Rash—Doxorubicin—liver cancer	0.000153	0.000892	CcSEcCtD
Amsacrine—TOP2A—Cell Cycle, Mitotic—PSMA4—liver cancer	0.000153	0.00127	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—PSMD10—liver cancer	0.000153	0.00127	CbGpPWpGaD
Amsacrine—Dermatitis—Doxorubicin—liver cancer	0.000153	0.000891	CcSEcCtD
Amsacrine—Headache—Doxorubicin—liver cancer	0.000152	0.000886	CcSEcCtD
Amsacrine—CYP2D6—Biological oxidations—GSTA1—liver cancer	0.000151	0.00126	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—PPARG—liver cancer	0.000151	0.00125	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—HPGDS—liver cancer	0.00015	0.00125	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—NAT2—liver cancer	0.00015	0.00124	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.00015	0.00124	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—TERT—liver cancer	0.000149	0.00124	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—NAT2—liver cancer	0.000148	0.00123	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CCND1—liver cancer	0.000147	0.00122	CbGpPWpGaD
Amsacrine—Nausea—Doxorubicin—liver cancer	0.000144	0.00084	CcSEcCtD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—CDKN1A—liver cancer	0.000143	0.00119	CbGpPWpGaD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—TP53—liver cancer	0.000138	0.00115	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—PSMA4—liver cancer	0.000137	0.00114	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—PSMD10—liver cancer	0.000137	0.00114	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000136	0.00113	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—RAF1—liver cancer	0.000136	0.00113	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—SERPINE1—liver cancer	0.000136	0.00113	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000134	0.00112	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PSMD10—liver cancer	0.000134	0.00111	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PSMA4—liver cancer	0.000134	0.00111	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000132	0.0011	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GOT2—liver cancer	0.00013	0.00108	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CASP3—liver cancer	0.00013	0.00108	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000128	0.00106	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—JUN—liver cancer	0.000126	0.00105	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	0.000126	0.00104	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000126	0.00104	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP2E1—liver cancer	0.000123	0.00102	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—HPGDS—liver cancer	0.00012	0.000995	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.000119	0.00099	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000119	0.000987	CbGpPWpGaD
Amsacrine—TOP2A—Mitotic G1-G1/S phases—MYC—liver cancer	0.000118	0.000983	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—CTNNB1—liver cancer	0.000118	0.00098	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000117	0.000973	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.000117	0.000971	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—MMP9—liver cancer	0.000116	0.000961	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYCS—liver cancer	0.000115	0.000954	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000115	0.000953	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	0.000114	0.000951	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GGT1—liver cancer	0.000113	0.000936	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GOT1—liver cancer	0.000113	0.000936	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000112	0.000928	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000111	0.000926	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000111	0.000919	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.00011	0.000919	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—BRAF—liver cancer	0.000109	0.000907	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	0.000109	0.000906	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000108	0.000898	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—JUN—liver cancer	0.000107	0.000889	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000105	0.000876	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—VEGFA—liver cancer	0.000104	0.000863	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—H2AFX—liver cancer	0.000103	0.00086	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—STAT3—liver cancer	0.000103	0.000854	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—MAPK8—liver cancer	0.000101	0.000841	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTP1—liver cancer	0.000101	0.000841	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—HMOX1—liver cancer	9.97e-05	0.000829	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP2E1—liver cancer	9.76e-05	0.000811	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	9.73e-05	0.000809	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—PCNA—liver cancer	9.68e-05	0.000805	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	9.62e-05	0.0008	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TGFB1—liver cancer	9.52e-05	0.000792	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TNF—liver cancer	9.47e-05	0.000787	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTM1—liver cancer	9.29e-05	0.000773	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—H2AFX—liver cancer	9.24e-05	0.000769	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—RAF1—liver cancer	9.11e-05	0.000757	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GGT1—liver cancer	8.96e-05	0.000745	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	8.95e-05	0.000744	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	8.93e-05	0.000743	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TNF—liver cancer	8.89e-05	0.00074	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—KRAS—liver cancer	8.82e-05	0.000734	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP1A1—liver cancer	8.81e-05	0.000733	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	8.75e-05	0.000728	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—PCNA—liver cancer	8.65e-05	0.00072	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	8.58e-05	0.000714	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TERT—liver cancer	8.36e-05	0.000695	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	8.34e-05	0.000693	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	8.27e-05	0.000688	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—MTHFR—liver cancer	8.21e-05	0.000683	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PPARA—liver cancer	8.06e-05	0.00067	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTP1—liver cancer	8.05e-05	0.000669	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	8.02e-05	0.000667	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	7.93e-05	0.00066	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	7.67e-05	0.000638	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	7.65e-05	0.000636	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CASP3—liver cancer	7.65e-05	0.000636	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL6—liver cancer	7.64e-05	0.000635	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL2—liver cancer	7.64e-05	0.000635	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	7.6e-05	0.000632	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—HRAS—liver cancer	7.5e-05	0.000624	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	7.5e-05	0.000623	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTM1—liver cancer	7.39e-05	0.000615	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	7.35e-05	0.000611	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	7.34e-05	0.00061	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	7.34e-05	0.00061	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	7.29e-05	0.000606	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.24e-05	0.000602	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—IL6—liver cancer	7.18e-05	0.000597	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TP53—liver cancer	7.06e-05	0.000587	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	7.01e-05	0.000583	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	6.94e-05	0.000577	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	6.91e-05	0.000575	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CG—liver cancer	6.9e-05	0.000574	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PPARG—liver cancer	6.66e-05	0.000554	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—AKT1—liver cancer	6.62e-05	0.000551	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	6.58e-05	0.000547	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—VEGFA—liver cancer	6.49e-05	0.00054	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—IL6—liver cancer	6.46e-05	0.000537	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN2A—liver cancer	6.4e-05	0.000532	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	6.21e-05	0.000516	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CD—liver cancer	6.07e-05	0.000504	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ALB—liver cancer	5.99e-05	0.000498	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TGFB1—liver cancer	5.96e-05	0.000495	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	5.78e-05	0.00048	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN2A—liver cancer	5.72e-05	0.000475	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	5.67e-05	0.000471	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN1B—liver cancer	5.66e-05	0.000471	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TNF—liver cancer	5.56e-05	0.000463	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—UGDH—liver cancer	5.56e-05	0.000463	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CCND1—liver cancer	5.4e-05	0.000449	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	5.36e-05	0.000445	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CB—liver cancer	5.29e-05	0.00044	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—UGDH—liver cancer	5.24e-05	0.000436	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—EPT1—liver cancer	5.23e-05	0.000435	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN1A—liver cancer	5.23e-05	0.000435	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN1B—liver cancer	5.06e-05	0.000421	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—HRAS—liver cancer	5.01e-05	0.000417	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TAT—liver cancer	4.96e-05	0.000412	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—EPT1—liver cancer	4.93e-05	0.00041	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CCND1—liver cancer	4.83e-05	0.000402	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	4.78e-05	0.000398	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN1A—liver cancer	4.67e-05	0.000389	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TAT—liver cancer	4.67e-05	0.000388	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MYC—liver cancer	4.33e-05	0.00036	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	4.2e-05	0.00035	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MYC—liver cancer	3.88e-05	0.000322	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	3.85e-05	0.00032	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	3.78e-05	0.000314	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	3.67e-05	0.000306	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	3.67e-05	0.000305	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	3.64e-05	0.000303	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	3.56e-05	0.000296	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	3.54e-05	0.000294	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	3.47e-05	0.000289	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GLUL—liver cancer	3.37e-05	0.00028	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CPT1B—liver cancer	3.37e-05	0.00028	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NR1H4—liver cancer	3.25e-05	0.00027	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CA—liver cancer	3.22e-05	0.000268	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	3.2e-05	0.000266	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA3—liver cancer	3.19e-05	0.000266	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—liver cancer	3.18e-05	0.000265	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CPT1B—liver cancer	3.18e-05	0.000264	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GLUL—liver cancer	3.18e-05	0.000264	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.07e-05	0.000256	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NR1H4—liver cancer	3.06e-05	0.000255	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA3—liver cancer	3.01e-05	0.00025	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	2.95e-05	0.000245	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	2.94e-05	0.000245	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA4—liver cancer	2.92e-05	0.000243	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA2—liver cancer	2.85e-05	0.000237	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA4—liver cancer	2.75e-05	0.000229	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA1—liver cancer	2.75e-05	0.000228	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.75e-05	0.000228	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.72e-05	0.000226	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NAT2—liver cancer	2.72e-05	0.000226	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA2—liver cancer	2.68e-05	0.000223	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKT1—liver cancer	2.63e-05	0.000219	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALDOB—liver cancer	2.6e-05	0.000217	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA1—liver cancer	2.59e-05	0.000215	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NAT2—liver cancer	2.56e-05	0.000213	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.5e-05	0.000208	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CRABP1—liver cancer	2.48e-05	0.000207	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.48e-05	0.000207	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALDOB—liver cancer	2.45e-05	0.000204	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.42e-05	0.000201	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CRABP1—liver cancer	2.34e-05	0.000195	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HPGDS—liver cancer	2.17e-05	0.000181	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HPGDS—liver cancer	2.05e-05	0.00017	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.04e-05	0.00017	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PSMA4—liver cancer	1.94e-05	0.000161	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PSMD10—liver cancer	1.94e-05	0.000161	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GOT2—liver cancer	1.88e-05	0.000157	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.85e-05	0.000153	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PSMD10—liver cancer	1.82e-05	0.000152	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PSMA4—liver cancer	1.82e-05	0.000152	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GOT2—liver cancer	1.77e-05	0.000148	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2E1—liver cancer	1.77e-05	0.000147	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.67e-05	0.000139	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP2E1—liver cancer	1.67e-05	0.000139	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYCS—liver cancer	1.66e-05	0.000138	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GOT1—liver cancer	1.63e-05	0.000135	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GGT1—liver cancer	1.63e-05	0.000135	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYCS—liver cancer	1.56e-05	0.00013	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GOT1—liver cancer	1.53e-05	0.000127	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GGT1—liver cancer	1.53e-05	0.000127	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTP1—liver cancer	1.46e-05	0.000121	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HMOX1—liver cancer	1.44e-05	0.00012	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTP1—liver cancer	1.38e-05	0.000114	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HMOX1—liver cancer	1.36e-05	0.000113	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTM1—liver cancer	1.34e-05	0.000112	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP1A1—liver cancer	1.27e-05	0.000106	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTM1—liver cancer	1.26e-05	0.000105	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP1A1—liver cancer	1.2e-05	9.97e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTHFR—liver cancer	1.19e-05	9.86e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARA—liver cancer	1.16e-05	9.67e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTHFR—liver cancer	1.12e-05	9.29e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARA—liver cancer	1.1e-05	9.12e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CG—liver cancer	9.96e-06	8.28e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARG—liver cancer	9.62e-06	8e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CG—liver cancer	9.39e-06	7.81e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARG—liver cancer	9.06e-06	7.53e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CD—liver cancer	8.76e-06	7.28e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ALB—liver cancer	8.65e-06	7.19e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CD—liver cancer	8.25e-06	6.86e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ALB—liver cancer	8.15e-06	6.77e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CB—liver cancer	7.63e-06	6.35e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CB—liver cancer	7.19e-06	5.98e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CA—liver cancer	4.65e-06	3.87e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CA—liver cancer	4.39e-06	3.65e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKT1—liver cancer	3.8e-06	3.16e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKT1—liver cancer	3.58e-06	2.98e-05	CbGpPWpGaD
